Replimune Group, Inc. (REPL) Earnings
NASDAQ·Healthcare·Biotechnology
$12.51
+11.70%
Mkt Cap $940.40M
EPS — Estimate vs Actual
Mkt Cap
$940.40M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$12.51
+11.70%
Mkt Cap $940.40M
Mkt Cap
$940.40M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58